VRBPAC Briefing Document Presented by Merck on 17 November 2010 Human papillomaviruses (HPV) cause a significant burden of benign and malignant anogenital disease in men and women. The HPV-related anogenital cancers all develop through a common pathogenetic process of neoplastic change that begins with the necessary event of HPV infection. After cervical cancer, the anogenital […]
PRESCRIBING INFORMATION FOR GARDASIL
INDICATIONS AND USAGE GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, and vaginal cancer caused by HPV types 16 and 18 Genital warts (condyloma acuminata) caused by HPV types […]
HPV Vaccine Adverse Events Increased Significantly in First Two Weeks of December
Press Release Immediate Release SANE Vax December 13, 2010 Two weeks ago SANE Vax researcher, Janny Stokvis of the Netherlands reported the latest VAERS data on deaths and injury from the HPV vaccines. Those numbers stood at: 20,575 adverse reactions 352 reports of abnormal pap smears post vaccination 89 reported deaths (plus 5 reports submitted […]
- « Previous Page
- 1
- …
- 56
- 57
- 58
